ATP-binding cassette transporters in macrophages: Promising drug targets for treatment of cardiovascular disease

Current Opinion in Investigational Drugs

Volumn 3, Issue 6, 2002, Pages 853-858

  Schmitz, Gerd ^a   Drobnik, Wolfgang ^a  

^a UNIVERSITY OF REGENSBURG   (United Kingdom)

Author keywords

ABCA1; Atherosclerosis; Filipodia; High density lipoprotein; LXR RXR; Rafts

Indexed keywords

[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; ABC A1 TRANSPORTER; ABC TRANSPORTER; ACETYLPODOCARPIC DIMER; CHOLESTEROL; FATTY ACID; HIGH DENSITY LIPOPROTEIN; HORMONE RECEPTOR; HORMONE RECEPTOR STIMULATING AGENT; LG 268; LIPID; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; MEMBRANE PROTEIN; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; RETINOID X RECEPTOR; STEROL; UNCLASSIFIED DRUG;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL TRANSPORT; CHOLESTEROL TRANSPORT; DISEASE PREDISPOSITION; DRUG EFFECT; DRUG TARGETING; FATTY ACID TRANSPORT; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HETEROZYGOTE; HOMEOSTASIS; HOMOZYGOTE; HORMONAL REGULATION; HUMAN; LIPID METABOLISM; LIPID VESICLE; LIPOPROTEIN METABOLISM; MACROPHAGE FUNCTION; MONOCYTE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CHOLESTEROL, HDL; CORONARY ARTERIOSCLEROSIS; HUMANS; MACROPHAGES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION, GENETIC;

EID: 0036628389     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Dean M, Hamon Y, Chimini G: The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res (2001) 42:1007-1017.
2. Klucken J, Buchler C, Orso E, Kaminski WE, Porsch-Ozcurumez M, Liebisch G, Kapinsky M, Diederich W, Drobnik W, Dean M, Allikmets R, Schmitz G: ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulatory of macrophage cholesterol and phospholipid transport. Proc Natl Acad Sci USA (2000) 97:817-822.
3. Langmann T, Klucken J, Reil M, Liebisch G, Luciani MF, Chimini G, Kaminski WE, Schmitz G: Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): Evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun (1999) 257:29-33.
4. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G: The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet (1999) 22:347-351.
5. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, Van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, Loubser O, Ouelette BF, Fichter K, Ashbourne-Excoffon KJ, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJ, Hayden MR: Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet (1999) 22:336-345.
6. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denefle P, Assmann G: Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet (1999) 22:352-355.
7. Orso E, Broccardo C, Kaminski WE, Bottcher A, Liebisch G, Drobnik W, Gotz A, Chambenoit O, Diederich W, Langmann T, Spruss T, Luciani MF, Rothe G, Lackner KJ, Chimini G, Schmitz G: Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and ABC1-deficient mice. Nat Genet (2000) 24:192-196.
8. Singaraja RR, Bocher V, James ER, Clee SM, Zhang LH, Leavitt BR, Tan B, Brooks-Wilson A, Kwok A, Bissada N, Yang YZ, Liu G, Tafuri SR, Fievet C, Wellington CL, Staels B, Hayden MR: Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1. J Biol Chem (2001) 276:33969-33979.
9. Van Dam MJ, De Groot E, Clee SM, Hovingh GK, Roelants R, Brooks-Wilson A, Zwinderman AH, Smit AJ, Smelt AH, Groen AK, Hayden MR, Kastelein JJ: Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: An observation study. Lancet (2002) 359:37-42.
10. Aiello RJ, Brees D, Bourassa PA, Royer L, Lindsey S, Coskran T, Haghpassand M, Francone OL: Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol (2002) 22:630-637. Selected inactivation of macrophage ABCA1 is accompanied by an increase in atherosclerotic lesion progression in hypercholesterolemic apoE-deficient and LDLR receptor-deficient mice, without significant effect on plasma HDL.
11. Van Eck M, Bos IS, Kaminski WE, Orso E, Rothe G, Twisk J, Bottcher A, Van Amersfoort ES, Christiansen-Weber TA, Fung-Leung WP, Van Berkel TJC, Schmitz G: Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci USA (2002) 99:6298-6303. LDL receptor knockout mice that are selectively deficient in leukocyte ABCA1 develop more advanced atherosclerosis lesions, without effect on plasma HDL levels. In addition, the amount of macrophages in liver and spleen and peripheral blood leukocyte counts is increased in animals deficient in leukocyte ABCA1.
12. Diederich W, Orso E, Drobnik W, Schmitz G: Apoliproprotein AI and HDL(3) inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC42. Atherosclerosis (2001) 159:313-324. Cellular cholesterol homeostasis regulates the formation of membrane extensions via cdc42. The apoA-I-induced inhibition of filipodia formation and chemotaxis of monocyte may be of relevance for recruitment of monocytes into the vessel wall
13. Tsukamoto K, Hirano K, Tsujii K, Ikegami C, Zhongyan Z, Nishida Y, Ohama T, Matsuura F, Yamashita S, Matsuzawa Y: ATP-binding cassette transporter-1 induces rearrangement of actin cytoskeletons possibly through Cdc42/N-WASP. Biochem Biophys Res Commun (2001) 287:757-65. Expression of ABCA1 in HEK293 cells stimulates the formation of long membrane protrusions, which is inhibited by a dominant negative form of cdc42. Co-immunprecipitation suggests a direct interaction between cdc42 and ABCA1.
14. Drobnik W, Borsukova H, Bottcher A, Pfeiffer A, Liebisch G, Schutz GJ, Schindler H, Schmitz G: Apo AI/ABCA1-dependent and HDL-3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains. Traffic (2002) 3:268-278. The paper provides a detailed comparison of the lipid and protein composition of two compositionally distinct cholesterol-based lipid microdomains, which are discriminated by their different solubility in Triton X-100 and Lubrol WX. ApoA-I and HDL differentially modify these raft domains in a cell-type specific manner, whereas apoA-I-mediated lipid efflux seems to primarily involve Lubrol rafts.
15. Roper K, Corbeil D, Huttner WB: Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol (2000) 2:582-592. The authors provide the first evidence that distinct cholesterol-based lipid microdomains can be distinguished by their different solubility in Triton X-100 and Lubrol WX. Domains that are soluble in Triton but insoluble in Lubrol were termed Lubrol rafts and found to be associated with membrane protrusions.
16. Von Eckardstein A, Langer C, Engel T, Schaukal I, Cignarella A, Reinhardt J, Lorkowski S, Li Z, Zhou X, Cullen P, Assmann G: ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages. FASEB J (2001) 15:1555-1561.
17. Lorkowski S, Kratz M, Wenner C, Schmidt R, Weitkamp B, Fobker M, Reinhardt J, Rauterberg J, Galinski EA, Cullen P: Expression of the ATP-binding cassette transporter gene ABCG1 (ABC8) in Tangier disease. Biochem Biophys Res Commun (2001) 283:821-830.
18. Kaminski WE, Orso E, Diederich W, Klucken J, Drobnik W, Schmitz G: Identification of a novel human sterol-sensitive ATP-binding cassette transporter (ABCA7). Biochem Biophys Res Commun (2000) 273:532-538.
19. Kaminski WE, Piehler A, Schmitz G: Genomic organization of the human cholesterol-responsive ABC transporter ABCA7: Tandem linkage with the minor histocompatibility antigen HA-1 gene. Biochem Biophys Res Commun (2000) 278:782-789.
20. Langmann T, Porsch-Ozcurumez M, Heimerl S, Probst M, Moehle C, Taher M, Borsukova H, Kielar D, Kaminski WE, Dittrich-Wengenroth E, Schmitz G: Identification of sterol-independent regulatory elements in the human ATP-binding cassette transporter A1 promoter. Role of Sp1/3, E-box binding factors, and an oncostatin M-responsive element. J Biol Chem (2002) 277:14443-14450. Oncostatin M-induced ABCA1 transcription provides a new concept on how members of the interleukin-6 family of cytokines may regulate lipid transport proteins.
21. Costet P, Luo Y, Wang N, Tall AR: Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem (2000) 275:28240-28245.
22. Venkateswaran A, Laffitte BA, Joseph SB, Mak PA, Wilpitz DC, Edwards PA, Tontonoz P: Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR α. Proc Natl Acad Sci USA (2000) 97:12097-12102.
23. Fu X, Menke JG, Chen Y, Zhou G, MacNaul KL, Wright SD, Sparrow CP, Lund EG: 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J Biol Chem (2001) 276:38378-38387. The paper indicates that 27-hydroxycholesterol but not other proposed LXR ligands, including 20(S)-hydroxycholesterol, 22(R)-hydroxycholesterol and 24(S)-25-epoxycholesterol, are regulators of ABCA1 expression in macrophages.
24. Sparrow CP, Baffic J, Lam MH, Lund EG, Adams AD, Fu X, Hayes N, Jones AB, MacNaul KL, Ondeyka J, Singh S, Wang J, Zhou G, Moller DE, Wright SD, Menke JG: A potent synthetic LXR agonist is more effective than cholesterol loading at inducing ABCA1 mRNA and stimulating cholesterol efflux. J Biol Chem (2002) 277:10021-10027.
25. Claudel T, Leibowitz MD, Fievet C, Tailleux A, Wagner B, Repa JJ, Torpier G, Lobaccaro JM, Paterniti JR, Mangelsdorf DJ, Heyman RA, Auwerx J: Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc Natl Acad Sci USA (2001) 98:2610-2615.
26. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, Staels B: PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med (2001) 7:53-58.
27. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, Evans RM, Tontonoz P: A PPAR γ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell (2001) 7:161-171.
28. Oliver Jr WR, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, Lewis MC, Winegar DA, Sznaidman ML, Lambert MH, Xu HE, Sternbach DD, Kliewer SA, Hansen BC, Willson TM: A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA (2001) 98:5306-5311.
29. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, Mangelsdorf DJ: Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science (2000) 289:1524-1529.
30. Drobnik W, Lindenthal B, Lieser B, Ritter M, Christiansen WT, Liebisch G, Giesa U, Igel M, Borsukova H, Buchler C, Fung-Leung WP, Von Bergmann K, Schmitz G: ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism. Gastroenterology (2001) 120:1203-1211.
31. Berge KE, Tian H, Graft GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R, Hobbs HH: Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science (2000) 290:1771-1775. The authors describe six mutations in ABCG8 and one in ABCG5 in nine patients with sitosterolemia. The two genes are expressed at highest levels in liver and intestine and, in mice, cholesterol feeding upregulates expression of both genes.
32. Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, Kojima H, Allikmets R, Sakuma N, Pegoraro R, Srivastava AK, Salen G, Dean M, Patel SB: Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet (2001) 27:79-83. The paper reports that a ABCG5 is mutant in nine unrelated sitosterolemia patients.
33. Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs HH, Mangelsdorf DJ: Regulation of ATP-binding cassette sterol transporters, ABCG5 and ABCG8, by the oxysterol receptors, LXRα and β. J Biol Chem (2002): In press.
34. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL, Mangelsdorf DJ: Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev (2000) 14:2819-2830.
35. Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, Lustig KD, Shan B: Role of LXRs in control of lipogenesis. Genes Dev (2000) 14:2831-2838.
36. Chambenoit O, Hamon Y, Marguet D, Rigneault H, Rosseneu M, Chimini G: Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter. J Biol Chem (2001) 276:9955-9960.
37. Wang N, Silver DL, Costet P, Tall AR: Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem (2000) 275:33053-33058.
38. Neufeld EB, Remaley AT, Demosky SJ, Stonik JA, Cooney AM, Comly M, Dwyer NK, Zhang M, Blanchette-Mackie J, Santamarina-Fojo S, Brewer Jr HB: Cellular localization and trafficking of the human ABCA1 transporter. J Biol Chem (2001) 276:27584-27590.
39. Szakacs G, Langmann T, Ozvegy C, Orso E, Schmitz G, Varadi A, Sarkadi B: Characterization of the ATPase cycle of human ABCA1: Implications for its function as a regulator rather than an active transporter. Biochem Biophys Res Commun (2001) 288:1258-1264. In contrast to ABC transporters which exert bona fide pump function, ABCA1, similar to the ABC regulator proteins CFTR and SUR, shows only marginal intrinsic ATPase activity, Thus, ABCA1 may be a transport regulator rather than an active pump.
40. Buchler C, Bottcher A, Maa Bared S, Ritter M, Schmitz G. Vesicular trafficking of ABCA1 is mediated by a direct interaction with β2 syntrophin. Biochem Biophys Res Commun (2002) 293:759-765.